Sponsors
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Research & Development
A personalised approach
Personalised medicines tailored to suit an individual’s genetic make-up could revolutionise the future of drug discovery. Frances Davies of NGP talks to Jan Lundberg of AstraZeneca about the revolutionary research needed to take advantage of this potential new direction.
Genotoxicity assessment in a changing world
With ever increasing pressure to reduce attrition rates in the search for new drugs, every aspect of the discovery-development process is being scrutinized to identify ways of making the process faster, cheaper and more efficient. Some productivi
Omes and omics
Systems biology has had a huge impact on the drug discovery process. But do scientists agree on what this relatively new biological study field comprises? And what impact do the new capabilities in genomics and proteomics have on the pharmaceutical industry? NGP asked Gentronix and Logopharm.
Protein complexes – challenges and opportunities for drug discovery
By Uwe Schulte, Logopharm GmbH, Germany
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.